Publicação
Equity research: novo nordisk
| datacite.subject.fos | Ciências Sociais::Economia e Gestão | pt_PT |
| dc.contributor.advisor | André, Rosário | |
| dc.contributor.author | Carati, Alessandro | |
| dc.date.accessioned | 2022-02-24T17:11:07Z | |
| dc.date.available | 2023-09-07T00:31:20Z | |
| dc.date.issued | 2021-09-21 | |
| dc.date.submitted | 2021-09-07 | |
| dc.description.abstract | The aim of the thesis is that to asses show the future will unfold for the pharma company Novo Nordisk taking into account the entry of a disruptive and innovative competitor: Virta Health. As we will later further develop, Novo Nordisk has a strong pipeline of products, with its main focus on Diabetes. As we will later further develop, Novo Nordisk has a strong pipeline of products, with its main focus on Diabetes. Market potential for diabetes lies mainly in diabetes Type 2 which accounts for 90% to 95% of diabetes cases. Virt a strictly targets Type 2 diabetes, setting itself apart by reversing the disease or preventing it on a whole, without the use of medicines but through a dietary solution. Let me take you on this journey: together we will discover the secrets of diabetes and the pharma industry. Thanks to scientific innovation and research, new solutions and cures are being discovered as you read. | pt_PT |
| dc.identifier.tid | 202837580 | pt_PT |
| dc.identifier.uri | http://hdl.handle.net/10362/133498 | |
| dc.language.iso | eng | pt_PT |
| dc.relation | Nova School of Business and Economics | |
| dc.subject | NN | pt_PT |
| dc.subject | Valuation | pt_PT |
| dc.subject | Pharmaceuticals | pt_PT |
| dc.subject | Virta health | pt_PT |
| dc.title | Equity research: novo nordisk | pt_PT |
| dc.type | master thesis | |
| dspace.entity.type | Publication | |
| oaire.awardNumber | UID/ECO/00124/2013 | |
| oaire.awardTitle | Nova School of Business and Economics | |
| oaire.awardURI | info:eu-repo/grantAgreement/FCT/6817 - DCRRNI ID/UID%2FECO%2F00124%2F2013/PT | |
| oaire.fundingStream | 6817 - DCRRNI ID | |
| project.funder.identifier | http://doi.org/10.13039/501100001871 | |
| project.funder.name | Fundação para a Ciência e a Tecnologia | |
| rcaap.rights | openAccess | pt_PT |
| rcaap.type | masterThesis | pt_PT |
| relation.isProjectOfPublication | 644a3f4f-817b-4d0d-aba6-f98cdca28bc7 | |
| relation.isProjectOfPublication.latestForDiscovery | 644a3f4f-817b-4d0d-aba6-f98cdca28bc7 | |
| thesis.degree.name | A Work Project, presented as part of the requirements for the Award of a Masters Degree in Finance from the NOVA – School of Business and Economics | pt_PT |
Ficheiros
Principais
1 - 1 de 1
A carregar...
- Nome:
- alessandro-carati---part-1.pdf
- Tamanho:
- 375.61 KB
- Formato:
- Adobe Portable Document Format
